| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
4,286 |
3,950 |
$209K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
4,020 |
3,685 |
$167K |
| 84443 |
Thyroid stimulating hormone (TSH) |
8,536 |
7,836 |
$129K |
| 80061 |
Lipid panel |
8,246 |
7,528 |
$104K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
13,848 |
12,261 |
$95K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
4,003 |
3,680 |
$95K |
| 80053 |
Comprehensive metabolic panel |
9,090 |
8,256 |
$87K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
5,268 |
4,776 |
$47K |
| 82274 |
|
2,645 |
2,462 |
$35K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,876 |
1,686 |
$34K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
850 |
799 |
$29K |
| 81001 |
|
10,016 |
9,070 |
$29K |
| 86703 |
|
2,450 |
2,197 |
$27K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
720 |
671 |
$25K |
| 86738 |
|
1,855 |
1,773 |
$24K |
| 84153 |
|
1,315 |
1,218 |
$23K |
| 86328 |
|
1,008 |
971 |
$18K |
| 82043 |
|
3,296 |
3,063 |
$18K |
| 82378 |
|
862 |
814 |
$15K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,032 |
515 |
$11K |
| 86803 |
|
781 |
708 |
$10K |
| 84436 |
|
1,457 |
1,343 |
$9K |
| 87276 |
|
754 |
722 |
$8K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,011 |
916 |
$8K |
| 87275 |
|
751 |
719 |
$8K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,054 |
936 |
$8K |
| 86677 |
|
552 |
510 |
$8K |
| 84479 |
|
1,123 |
1,028 |
$6K |
| 36415 |
Collection of venous blood by venipuncture |
915 |
879 |
$6K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
104 |
103 |
$5K |
| 84439 |
|
603 |
554 |
$5K |
| 80074 |
|
93 |
85 |
$5K |
| 82607 |
|
311 |
268 |
$5K |
| 86592 |
|
1,130 |
1,046 |
$4K |
| 82570 |
|
826 |
755 |
$4K |
| 82947 |
|
943 |
809 |
$3K |
| 84156 |
|
659 |
610 |
$2K |
| 85730 |
|
334 |
279 |
$2K |
| 80050 |
General health panel |
172 |
163 |
$2K |
| 82270 |
|
552 |
475 |
$1K |
| 84702 |
|
97 |
79 |
$1K |
| 85610 |
|
411 |
349 |
$1K |
| 85651 |
|
402 |
363 |
$1K |
| 82575 |
|
225 |
164 |
$876.80 |
| 83655 |
|
42 |
34 |
$448.46 |
| 87177 |
|
48 |
40 |
$297.33 |
| 84520 |
|
141 |
102 |
$227.58 |
| 86140 |
|
42 |
42 |
$225.63 |
| 86038 |
|
14 |
14 |
$185.34 |
| 82951 |
|
13 |
13 |
$183.14 |
| 84478 |
|
61 |
55 |
$178.37 |
| 87184 |
|
257 |
200 |
$140.35 |
| 82465 |
|
63 |
57 |
$139.74 |
| 83540 |
|
13 |
13 |
$85.64 |
| 84550 |
|
12 |
12 |
$50.97 |
| 84450 |
|
36 |
30 |
$22.80 |
| 84460 |
|
34 |
29 |
$15.74 |
| 84075 |
|
17 |
12 |
$12.56 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
412 |
393 |
$0.00 |
| 3044F |
|
15 |
15 |
$0.00 |
| 3048F |
|
18 |
18 |
$0.00 |